InvestorsHub Logo
Followers 1323
Posts 22655
Boards Moderated 3
Alias Born 11/15/2011

Re: kalstone post# 91871

Monday, 09/29/2014 8:41:30 PM

Monday, September 29, 2014 8:41:30 PM

Post# of 113924
MMTC - Everything you said is true, the company is on a tight budget, they are not thieving. If this were a scam insiders would be paying themselves extraordinary salaries funded by selling massive amounts of shares, this is not the case with MMTC, the OS only increased by 3.5 Million in the last six months, the company is on a tight budget. Dr. Haavig is hard at work in the lab working on identifiers, progress is being made. Once all the identifiers are complete the MIT will be ready for a successful marketing campaign. We're racing the clock, the quicker we see sales revenue, the sooner the dilution will stop all together. Mr. Nunez has stated he only needs to sell 2 MIT's a month to meet the current burn rate. We all know there is nothing out there like the MIT, there is virtually no competition, the MIT should more than sell itself once the identifiers are completed. In the meantime, like most biotech's in the late stages of development, MMTC is ignored by investors while hard at work testing and developing its product. We're a cash starved biotech with no revenue at present, the dilution will continue until we see revenue. Fortunately insiders continue to fund operations and dilution has been minimal, we have to be getting close.

-IMHO